4.8 Article

Nonlinearity of Cationic Aromatic Amine Sorption to Aluminosilicates and Soils: Role of Intermolecular Cation-π Interactions

期刊

ENVIRONMENTAL SCIENCE & TECHNOLOGY
卷 47, 期 24, 页码 14119-14127

出版社

AMER CHEMICAL SOC
DOI: 10.1021/es403389a

关键词

-

资金

  1. NSF ADVANCE-PAID [0620101, 0620087]
  2. Fletcher Family Fund (Bowdoin College)
  3. Clare Boothe Luce Foundation
  4. Coles, Freedman, Hughes Family
  5. Division Of Human Resource Development
  6. Direct For Education and Human Resources [0620101, 0620087] Funding Source: National Science Foundation

向作者/读者索取更多资源

Through the study of substituted anilines and benzylamines, we demonstrated that cooperative cation-pi, pi-pi, and van der Waals interactions can increase aromatic cationic amine sorption to Na/Ca-montmorillonite well beyond the extent expected by cation exchange alone. Cationic amines exhibiting cooperative interactions displayed nonlinear S-shaped isotherms and increased affinity for the sorbent at low surface coverage; parallel cation exchange and cooperative interactions were noted above a sorption threshold of 0.3-2.3% of exchange sites occupied. Our experiments revealed the predominance of intermolecular cation-pi interactions, which occurred between the pi system of a compound retained on the surface via cation exchange and the cationic amine group of an adjacent molecule. Compounds with greater amine charge/area and electron-donating substituents that allowed for greater electron density at the center of the aromatic ring showed a greater potential for cation-pi interactions on montmorillonite surfaces. However, benzylamine sorption to nine soils, at charge loadings comparable to the experiments with montmorillonite, revealed no significant cooperative interactions. It appears that cation-pi interactions may be likely in soils with exceptionally high cation exchange capacities (>0.7 mol charge/kg) and low organic matter contents, abundant in montmorillonite and other expanding clay minerals.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Urology & Nephrology

Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer COMMENT

Daniel R. Dickstein, Deborah C. Marshall

Summary: Limited information is available on the effects of prostate cancer therapies on sexual health outcomes in sexual and gender minority patients. Understanding these outcomes is crucial for personalized clinical decision-making and creating a more equitable health system.

NATURE REVIEWS UROLOGY (2022)

Article Medicine, Research & Experimental

High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral Tongue

Brianna M. Jones, Dillan F. Villavisanis, Eric J. Lehrer, Daniel R. Dickstein, Kunal K. Sindhu, Krzysztof J. Misiukiewicz, Marshall Posner, Jerry T. Liu, Vishal Gupta, Sonam Sharma, Scott A. Roof, Marita Teng, Eric M. Genden, Richard L. Bakst

Summary: This study compared the clinical characteristics and outcomes of young patients without prior drinking or smoking history with squamous cell carcinoma of the oral tongue (SCCOT) to older patients. It found that young patients had lower rates of locoregional control and distant metastasis-free survival compared to older patients. Age was an independent predictor of distant metastasis-free survival, and advanced stage was a predictor of disease-specific survival.

LARYNGOSCOPE (2023)

Review Oncology

Management of Older Adults with Locally Advanced Head and Neck Cancer

Daniel R. Dickstein, Eric J. Lehrer, Kristin Hsieh, Alexandra Hotca, Brianna M. Jones, Ann Powers, Sonam Sharma, Jerry Liu, Vishal Gupta, Loren Mell, Zain Husain, Diana Kirke, Krzysztof Misiukiewicz, Marshall Posner, Eric Genden, Richard L. Bakst

Summary: Approximately one third of head and neck cancer patients are older adults, but they are significantly underrepresented in clinical trials. There is no clear consensus on the optimal treatment for older adults with head and neck cancer due to variations in their functional and performance status, medical comorbidities, and medication management. Novel predictive scores are being developed and ongoing clinical trials are investigating less intensive treatments for this population.

CANCERS (2022)

Review Oncology

The Cognitive Effects of Radiotherapy for Brain Metastases

Eric J. J. Lehrer, Brianna M. M. Jones, Daniel R. R. Dickstein, Sheryl Green, Isabelle M. M. Germano, Joshua D. D. Palmer, Nadia Laack, Paul D. D. Brown, Vinai Gondi, Jeffrey S. S. Wefel, Jason P. P. Sheehan, Daniel M. M. Trifiletti

Summary: Brain metastases are common intracranial neoplasms, with WBRT showing good intracranial tumor control rates but lacking survival benefits and causing cognitive decline and quality of life issues. Strategies such as incorporating memantine and hippocampal avoidance, as well as using SRS, have shown improved outcomes in recent years.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

What Rectal Cancer Patients May Be Able to Safely Avoid Radiation?

Daniel R. Dickstein, Michael Buckstein

Summary: The purpose of this review is to investigate why, how, and when radiation can be omitted from rectal cancer management. Recent findings suggest that low-risk rectal cancer cases may not require neoadjuvant radiation and alternative therapies such as MRI-directed therapy, chemotherapy alone, and immunotherapy could be potential options for omitting radiation in the future.

CURRENT COLORECTAL CANCER REPORTS (2023)

Editorial Material Oncology

Inclusion of Sexual Orientation and Gender Identity in Clinical Trials Is Necessary for Health Equity

Eric Chen, Daniel R. Dickstein, Uriel Kim, Nicholas Zaorsky, Parag Sanghvi

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Review Oncology

Gender-Affirming Surgery and Cancer : Considerations for Radiation Oncologists for Pelvic Radiation in Transfeminine Patients

Alicia C. Smart, Kevin X. Liu, Jason D. Domogauer, Carlos Rodriguez-Russo, Brianna Jones, Daniel R. Dickstein, Joseph D. Mancias, Ron Y. Shiloh, Anton Wintner, Anthony L. Zietman, Deborah C. Marshall, M. Aiven Dyer, Andrea L. Russo

Summary: Access to gender-affirming surgery is increasing in the United States, and radiation oncologists need to be prepared to treat patients who have undergone such surgeries. However, there are currently no guidelines for radiation treatment planning in these patients, and most oncologists lack training in the unique needs of transgender individuals with cancer. This review explores common gender-affirming surgeries for transfeminine people and summarizes the existing literature on cancer treatment in these patients. Additionally, it describes a systematic treatment approach and rationale for pelvic radiation treatment planning.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Review Urology & Nephrology

Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer

Daniel R. Dickstein, Collin R. Edwards, Eric J. Lehrer, Elizabeth S. Tarras, Matthew Gallitto, John Sfakianos, Matthew D. Galsky, Richard Stock, Joshua D. Safer, B. R. Simon Rosser, Deborah C. Marshall

Summary: Prostate cancer treatment has significant effects on sexual health and function, but research on its impact on sexual and gender minority populations is limited.

NATURE REVIEWS UROLOGY (2023)

Article Multidisciplinary Sciences

The intracellular domain of major histocompatibility class-I proteins is essential for maintaining excitatory spine density and synaptic ultrastructure in the brain

Maciej J. J. Lazarczyk, Brett A. A. Eyford, Merina Varghese, Hitesh Arora, Lonna Munro, Tahia Warda, Cheryl G. G. Pfeifer, Allison Sowa, Daniel R. R. Dickstein, Timothy Rumbell, Wilfred A. A. Jefferies, Dara L. L. Dickstein

Summary: MHC-I proteins are expressed in neurons and regulate synaptic plasticity, but their mechanisms in the CNS are still unknown. This study provides the first structural analysis of a MHC-I protein, revealing its underlying mechanisms in the brain. The Y321F mutation of MHC-I affects spine density and synaptic structure in the hippocampus, without impacting neuronal complexity, and mimics the phenotype of MHC-I knock-out animals, suggesting a crucial role of reverse, outside-in signaling events in regulating synaptic plasticity.

SCIENTIFIC REPORTS (2023)

Review Geriatrics & Gerontology

Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer

Daniel R. Dickstein, Ann E. Powers, Dragan Vujovic, Scott Roof, Richard L. Bakst

Summary: Approximately 30% of HNSCC patients are elderly, but they are underrepresented in clinical trials. This raises concerns about the appropriate management of HNSCC in this population. Surgical approaches carry higher risks for older adults, and radiation therapy can be challenging for them, potentially leading to compromised outcomes and quality of life. Current clinical trials are exploring new treatment options for HNSCC in older adults.

CLINICAL INTERVENTIONS IN AGING (2023)

Article Medicine, General & Internal

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy

Alexander Ruehle, Sebastian Marschner, Marlen Haderlein, Alexander Fabian, Maria Weymann, Max Behrens, Carolin Senger, Daniel R. Dickstein, Johannes Kraft, Jens von der Gruen, Eric Chen, Todd Aquino-Michaels, Justus Domschikowski, Amanda Bickel, Alev Altay-Langguth, Goda Kalinauskaite, Victor Lewitzki, Konstantinos Ferentinos, Constantinos Zamboglou, Soeren Schnellhardt, Erik Haehl, Simon K. B. Spohn, Eleni Gkika, Daniela Zoeller, Matthias Guckenberger, Volker Budach, Claus Belka, Richard Bakst, Arnulf Mayer, Heinz Schmidberger, Anca-Ligia Grosu, Panagiotis Balermpas, Carmen Stromberger, Nils H. Nicolay

Summary: This study aimed to investigate whether the addition of chemotherapy or cetuximab to radiotherapy improves survival in older adults with HNSCC. The results showed that chemoradiation, but not cetuximab-based bioradiotherapy, was associated with longer overall survival compared to radiotherapy alone. Additionally, the addition of chemotherapy also prolonged progression-free survival. Rating: 8/10.

JAMA NETWORK OPEN (2023)

Review Biochemistry & Molecular Biology

Radiotherapy and Immunotherapy in Lung Cancer

Kristin Hsieh, Daniel R. Dickstein, Juliana Runnels, Eric J. Lehrer, Kenneth Rosenzweig, Fred R. Hirsch, Robert M. Samstein

Summary: The emergence of immune checkpoint inhibitors (ICIs) has highlighted the important role of the immune system in cancer treatment. ICIs are being investigated and incorporated into the treatment paradigm for lung cancers at different stages and histology. Currently, definitive concurrent chemoradiotherapy followed by consolidative durvalumab is the recommended treatment for lung cancers including radiotherapy with ICI, but there are other recommendations for ICI with chemotherapy and/or surgery.

BIOMEDICINES (2023)

Review Biochemistry & Molecular Biology

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer

Juliana Runnels, Julie R. Bloom, Kristin Hsieh, Daniel R. Dickstein, Yuhao Shi, Brianna M. Jones, Eric J. Lehrer, Richard L. Bakst

Summary: Head and neck squamous cell carcinoma (HNSCC) is a prevalent and deadly disease worldwide. Immunotherapy has shown promise as a treatment option for HNSCC, and combining it with radiation therapy (RT) may enhance effectiveness. This review highlights the advantages of combining RT and immunotherapy, such as improved tumor response rates, increased survival, and reduced toxicity, while also discussing the challenges in redefining the standard of care and the need for further research.

BIOMEDICINES (2023)

Editorial Material Oncology

Do ask, do tell: improving health outcomes for sexual and gender minorities with cancer

Daniel R. Dickstein, Eric Chen, Nicholas G. Zaorsky, Karen Hoffman, Paul Nguyen

JNCI CANCER SPECTRUM (2023)

Article Marine & Freshwater Biology

Hyperbaric oxygen for COVID-19 patients with severe hypoxia prior to vaccine availability

Deepa Jansen, Daniel R. Dickstein, Kasandra Erazo, Ellen Stacom, David C. Lee, Sandra K. Wainwright

Summary: This study assessed the use of HBO2 therapy as a therapeutic intervention for hospitalized COVID-19 patients. The unadjusted analysis showed a significant reduction in inpatient mortality in the HBO2 treatment group, but there was no significant difference after adjusting for age and baseline hypoxia.

UNDERSEA AND HYPERBARIC MEDICINE (2022)

暂无数据